The World Health Organization’s director general has pledged to support countries to maximise the benefits of digital health, but said that governance and ethics are major issues that must
UCB/Amgen’s osteoporosis drug Evenity (romosozumab) looks set for approval in Europe after regulators finally recommended it, following a successful appeal against a rejection with help fro
Supplies of the heartburn drug ranitidine have been recalled globally following a cancer scare involving multiple pharma companies, where a carcinogenic impurity is suspected to be present
Novartis’ AveXis unit has given its reasons for refusing to supply its spinal muscular atrophy gene therapy Zolgensma to a seriously ill child in Belgium, saying compassionate use rules do